"
Team:Stanford-Brown/HumanPractices/PatentEthics
From 2012.igem.org
Vishesh.jain (Talk | contribs) (Created page with "{{:Team:Stanford-Brown/Templates/Main}} <html> <div id="subHeader"> <ul id="subHeaderList"> <li><a href="/Team:Stanford-Brown/HumanPractices/Introduction">Introduction</a></li> <...") |
(→Patent Ethics) |
||
| (6 intermediate revisions not shown) | |||
| Line 3: | Line 3: | ||
<div id="subHeader"> | <div id="subHeader"> | ||
<ul id="subHeaderList"> | <ul id="subHeaderList"> | ||
| + | <li><a href="/Team:Stanford-Brown/HumanPractices/Introduction" id="project">Human Practices:</a></li> | ||
<li><a href="/Team:Stanford-Brown/HumanPractices/Introduction">Introduction</a></li> | <li><a href="/Team:Stanford-Brown/HumanPractices/Introduction">Introduction</a></li> | ||
<li><a href="/Team:Stanford-Brown/HumanPractices/PatentGuide">Patent Guide</a></li> | <li><a href="/Team:Stanford-Brown/HumanPractices/PatentGuide">Patent Guide</a></li> | ||
| Line 14: | Line 15: | ||
== '''Patent Ethics''' == | == '''Patent Ethics''' == | ||
| - | + | In addition to the Synbio Community’s practical need for a guide to help navigate patent law, we also felt it would be invaluable to invigorate the discussion surrounding the ethics of gene patents. Thus we crafted a gene patent ethics review to complement our more practical guide. This review includes two documents, a full paper on the topic as well as an “at a glance” document for those who want to start thinking about these issues in a less rigorous fashion. | |
| + | |||
| + | As an introduction, it has been estimated that approximately 20% of the human genome is patented . While this is a generalized statement, most would find this notion, at least in part, unsettling. As synthetic biology is a relatively new field with unprecedented possibilities, indubitably, there is a great debate surrounding gene patenting in moral, practical, and legal domains. | ||
| + | |||
| + | The two documents below seek to elucidate the variety of dilemmas that the synbio-patent interaction has provoked and to hopefully offer some objective commentary and insight for the iGEM and greater synthetic biology community. | ||
| + | |||
| + | '''[https://static.igem.org/mediawiki/2012/a/a5/AtAGlance.pdf Patent Ethics: At a Glance]''' | ||
| + | |||
| + | '''[https://static.igem.org/mediawiki/2012/d/dc/Gene_Ethics.pdf Ethics of Gene Patenting: Moral, Legal, and Practical Perspectives]''' | ||
Latest revision as of 00:46, 4 October 2012
Patent Ethics
In addition to the Synbio Community’s practical need for a guide to help navigate patent law, we also felt it would be invaluable to invigorate the discussion surrounding the ethics of gene patents. Thus we crafted a gene patent ethics review to complement our more practical guide. This review includes two documents, a full paper on the topic as well as an “at a glance” document for those who want to start thinking about these issues in a less rigorous fashion.
As an introduction, it has been estimated that approximately 20% of the human genome is patented . While this is a generalized statement, most would find this notion, at least in part, unsettling. As synthetic biology is a relatively new field with unprecedented possibilities, indubitably, there is a great debate surrounding gene patenting in moral, practical, and legal domains.
The two documents below seek to elucidate the variety of dilemmas that the synbio-patent interaction has provoked and to hopefully offer some objective commentary and insight for the iGEM and greater synthetic biology community.
Ethics of Gene Patenting: Moral, Legal, and Practical Perspectives
